Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Cai

Showing results (841-850 of 908) with videos related to

Pageof 91
Sort By:
Emerging Microbes & Infections|February 15, 2021
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune responseChun-Lan Zhuang, Zhi-Jie Lin, Zhao-Feng Bi, et al.
Plos One|June 5, 2012
Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infantsFeng-Cai Zhu, Zheng-Lun Liang, Fan-Yue Meng, et al.
Nature Cell Biology|April 21, 2025
Mitochondrial NADPH fuels mitochondrial fatty acid synthesis and lipoylation to power oxidative metabolismDohun Kim, Rushendhiran Kesavan, Kevin Ryu, et al.
The Lancet. Infectious Diseases|May 22, 2023
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trialJun-Dong Wu, Jing-Xin Li, Jian Liu, et al.
Microbiology Spectrum|August 10, 2022
Genome of <i>Pythium myriotylum</i> Uncovers an Extensive Arsenal of Virulence-Related Genes among the Broad-Host-Range Necrotrophic <i>Pythium</i> Plant PathogensPaul Daly, Dongmei Zhou, Danyu Shen, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 5, 2009
[Epidemiological characteristic of first case of locally identified A/H1N1 secondary cases caused by imported source of infection in China]Zhi-Cong Yang, Tie-Gang Li, Yu-Fei Liu, et al.
Science Bulletin|April 15, 2020
Severe human infection with a novel avian-origin influenza A(H7N4) virusXiang Huo, Lun-Biao Cui, Cong Chen, et al.
Chinese Medical Journal|April 30, 2021
Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trialsHong-Xing Pan, Jian-Kai Liu, Bao-Ying Huang, et al.
The Journal of Clinical Investigation|March 17, 2026
L-2-hydroxyglutarate impairs neuronal differentiation through epigenetic activation of MYC expressionWen Gu, Xun Wang, Ashley Solmonson, et al.
Expert Review of Vaccines|September 1, 2022
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and aboveZhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, et al.
Pageof 91

Showing results (841-850 of 908) with videos related to

Sort By:
Pageof 91
Emerging Microbes & Infections|February 15, 2021
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune responseChun-Lan Zhuang, Zhi-Jie Lin, Zhao-Feng Bi, et al.
Plos One|June 5, 2012
Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infantsFeng-Cai Zhu, Zheng-Lun Liang, Fan-Yue Meng, et al.
Nature Cell Biology|April 21, 2025
Mitochondrial NADPH fuels mitochondrial fatty acid synthesis and lipoylation to power oxidative metabolismDohun Kim, Rushendhiran Kesavan, Kevin Ryu, et al.
The Lancet. Infectious Diseases|May 22, 2023
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trialJun-Dong Wu, Jing-Xin Li, Jian Liu, et al.
Microbiology Spectrum|August 10, 2022
Genome of <i>Pythium myriotylum</i> Uncovers an Extensive Arsenal of Virulence-Related Genes among the Broad-Host-Range Necrotrophic <i>Pythium</i> Plant PathogensPaul Daly, Dongmei Zhou, Danyu Shen, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 5, 2009
[Epidemiological characteristic of first case of locally identified A/H1N1 secondary cases caused by imported source of infection in China]Zhi-Cong Yang, Tie-Gang Li, Yu-Fei Liu, et al.
Science Bulletin|April 15, 2020
Severe human infection with a novel avian-origin influenza A(H7N4) virusXiang Huo, Lun-Biao Cui, Cong Chen, et al.
Chinese Medical Journal|April 30, 2021
Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trialsHong-Xing Pan, Jian-Kai Liu, Bao-Ying Huang, et al.
The Journal of Clinical Investigation|March 17, 2026
L-2-hydroxyglutarate impairs neuronal differentiation through epigenetic activation of MYC expressionWen Gu, Xun Wang, Ashley Solmonson, et al.
Expert Review of Vaccines|September 1, 2022
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and aboveZhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, et al.
Pageof 91